Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Share-based Compensation (Details Textual)

v3.20.2
Note 9 - Share-based Compensation (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) 700,000 700,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) $ 267.79 $ 190.39
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) $ 56.71 $ 36.72
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in shares) 116,816 93,596
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value $ 16,900 $ 11,600
Share-based Payment Arrangement, Expense 13,333 8,800
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total $ 53,200  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) 2 years 1 month 6 days  
Selling, General and Administrative Expenses [Member]    
Share-based Payment Arrangement, Expense $ 12,900 8,400
Cost of Sales [Member]    
Share-based Payment Arrangement, Expense $ 500 $ 400
Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) $ 22,367 $ 30,858
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) 267.87 192.08
Restricted Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) $ 267.98 $ 190.65
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 8,675 11,438